Figure 6.
Effects of pretraining, preretention, and immediate post-training muscimol infusions on eyeblink CRs and USVs. A, Mean CR percentage (±SE) from CONT (○, n = 6), pretraining MUSC infusion (▿, n = 6), preretention MUSC infusion (□, n = 6), and post-training MUSC infusion (⋄, n = 5) groups. (Filled symbols denote training sessions with muscimol infusions.) B, Mean USV duration recorded during training sessions. C, Comparison of mean CR percentage (±SE) displayed by pretraining MUSC, CONT, and post-training MUSC groups during equivalent sessions (M1, M2, and M3 indicate sessions with pretraining muscimol infusions). D, Mean CR percentage and USV duration (+SE) of preretention MUSC group (M5, M6, and M7 indicate sessions with pretraining muscimol infusions; *p < 0.05; **p < 0.01). E, Effects of muscimol infusions on the ratio of residual UR amplitude to US intensity. F, Location of muscimol infusion sites on the basis of a reconstruction of injection cannula placements in the basolateral amygdalar complex (pretraining MUSC, ▪; preretention MUSC, ○; post-training MUSC, □).